SCHEMBL10015065

SCHEMBL10015065

OC(O)c1cccc2c1sc1ccccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.48
ALOX5 P09917 1/20 0.45
PARP14 Q460N5 1/20 0.42
MAPT P10636 4/20 0.38
RAB9A P51151 3/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
ALDH1A1 P00352 4/20 0.36
HPGD P15428 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ALOX15 P16050 1/20 0.35
LIMK1 P53667 1/20 0.35
CDK5 Q00535 1/20 0.35
CDK5R1 Q15078 1/20 0.35
L3MBTL1 Q9Y468 3/20 0.35
TNKS O95271 2/20 0.35
TNKS2 Q9H2K2 2/20 0.35
ERCC5 P28715 1/20 0.35
FEN1 P39748 1/20 0.35
HCRTR1 O43613 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1102404 0.81 GPR3 (0.48) GPR3ALOX5PARP14MAPTRAB9A
SCHEMBL22924517 0.81 GPR3 (0.48) GPR3ALOX5PARP14MAPTRAB9A
SCHEMBL23056977 0.78 GPR3 (0.45) GPR3ALOX5PARP14MAPTRAB9A
SCHEMBL22161912 0.78 GPR3 (0.45) GPR3ALOX5PARP14MAPTRAB9A
SCHEMBL9686440 0.77 GPR3 (0.43) GPR3ALOX5PARP14MAPTRAB9A
SCHEMBL11196714 0.76 PARP14 (0.46) GPR3ALOX5PARP14RAB9AALDH1A1
SCHEMBL9963712 0.75 TSHR (0.46) GPR3ALOX5PARP14MAPTRAB9A
SCHEMBL20160627 0.75 TSHR (0.46) GPR3ALOX5PARP14MAPTRAB9A
SCHEMBL18926674 0.74 ALOX5 (0.47) GPR3ALOX5PARP14MAPTRAB9A
SCHEMBL15497424 0.74 GPR3 (0.68) GPR3ALOX5PARP14MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8628864-B2 Indolo[3,2,1-jk]carbazole compound and organic light-emitting device containing the same CANON KABUSHIKI KAISHA (JP) 2014-01-14 US disclosed
US-8628864-B2 Indolo[3,2,1-jk]carbazole compound and organic light-emitting device containing the same CANON KABUSHIKI KAISHA (JP) 2014-01-14 US disclosed
US-20120075273-A1 INDOLO[3,2,1-JK]CARBAZOLE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME CANON KABUSHIKI KAISHA (JP) 2012-03-29 US disclosed
US-20120075273-A1 INDOLO[3,2,1-JK]CARBAZOLE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME CANON KABUSHIKI KAISHA (JP) 2012-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120075273-A1 INDOLO[3,2,1-JK]CARBAZOLE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME HTR3D, SYMPK, NLK GPR3 413/4885ALOX5 1491/4885PARP14 785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.